相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2D-echocardiography vs cardiac MRI strain: a prospective cohort study in patients with HER2-positive breast cancer undergoing trastuzumab
Nathalie Bouwer et al.
CARDIOVASCULAR ULTRASOUND (2021)
Personalized screening intervals for kidney function in patients with chronic heart failure: a modeling study
Anne-Sophie Schuurman et al.
JOURNAL OF NEPHROLOGY (2021)
Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D-Dimer analysis: A prospective study
Florian Posch et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
A Prospective Study About Trastuzumab-induced Cardiotoxicity in HER2-positive Breast Cancer
Wala Ben Kridis et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2020)
Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction
Biniyam G. Demissei et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
The Role of Biomarkers in Cardio-Oncology
Kajaluxy Ananthan et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2020)
ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations
Emanuel Raschi et al.
INTERNAL AND EMERGENCY MEDICINE (2018)
Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer
Maria C. Arciniegas Calle et al.
BMC CANCER (2018)
Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy
Daniela Cardinale et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2017)
Role of Troponins I and T and N-Terminal Prohormone of Brain Natriuretic Peptide in Monitoring Cardiac Safety of Patients With Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Trastuzumab: A Herceptin Adjuvant Study Cardiac Marker Substudy
Dimitrios Zardavas et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma
Vivek Narayan et al.
CLINICAL CANCER RESEARCH (2017)
Personalized screening intervals for biomarkers using joint models for longitudinal and survival data
Dimitris Rizopoulos et al.
BIOSTATISTICS (2016)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
Jose Luis Zamorano et al.
EUROPEAN HEART JOURNAL (2016)
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial
Luca Gianni et al.
LANCET ONCOLOGY (2016)
Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto-GBG 69): a randomised, phase 3 trial
Michael Untch et al.
LANCET ONCOLOGY (2016)
NT-proBNP as Early Marker of Subclinical Late Cardiotoxicity after Doxorubicin Therapy and Mediastinal Irradiation in Childhood Cancer Survivors
Amal Zidan et al.
DISEASE MARKERS (2015)
Dynamic Predictions and Prospective Accuracy in Joint Models for Longitudinal and Time-to-Event Data
Dimitris Rizopoulos
BIOMETRICS (2011)
Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: Effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide
Mauro Feola et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
N-Terminal Pro-B–Type Natriuretic Peptide Plasma Levels as a Potential Biomarker for Cardiac Damage After Radiotherapy in Patients With Left-Sided Breast Cancer
Maria P. D’Errico et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study
Emily Ho et al.
HEART (2010)
Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
Daniela Cardinale et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults
Fotini Dodos et al.
CLINICAL RESEARCH IN CARDIOLOGY (2008)
分享论文
